Tumores carcinoidesopciones de tratamiento y estrategia quirúrgica

  1. C. González Puga 1
  2. B. Mirón Pozo 1
  3. F. Bravo Bravo 1
  4. F. Pérez Benítez 1
  5. J. Ruiz Castillo 1
  6. J. de la Maza Inza 1
  1. 1 Unidad de Coloproctología. Servicio de Cirugía General y de Ap. Digestivo. Prof. JMª García Gil. Hospital Universitario San Cecilio. Granada
Revista:
Cirugía Andaluza

ISSN: 2695-3811,  1130-3212

Año de publicación: 2009

Volumen: 20

Número: 1

Páginas: 44-51

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: Cirugía Andaluza

Referencias bibliográficas

  • Moertel CG: Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 5 1987; 10: 1502-22.
  • Ortiz V, Nicolás D, Pastor MA, Olaso V, Berenguer j. Síndrome carcinoide: avances en diagnóstico y tratamiento. Rev Esp Enferm Dig 1999; 91: 61-9.
  • Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet 1998; 352: 799-805.
  • Caplin ME, Hodgson HJ, Dhillon AP, Begent R, Buscombe J, Dick R, et al. Multimodality treatment for gastric carcinoid tumour with liver metastases. Am J Gastroenterol 1998, 93: 1945- 8.
  • Creutzfeldt W. Historical background and natural history of carcinoids. Digestion 1994, 55 (Suppl 3): 3-10.
  • Sandor A, Modlin IM. A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastroenterol 1998; 93: 422-8.
  • Norton JA. Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease. Digestion 1994; 55 (Suppl 3): 98-103.
  • Harris AJ, Redfern JS. Octeotride treatment of carcinoid syndrome: analysis of published dose-tritation data. Aliment Pharmacol Ther 1995; 9: 387-94.
  • Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999; 340: 858-68.
  • Neary PC, Redmond PH, Houghton T, Watson GRK, BouchierHayes D. Carcinoid disease. Review of the literature. Dis Colon Rectum 1997; 40: 349-62.
  • Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 1995; 90: 338-52.
  • Memon MA, Nelson H. Gastrointestinal carcinoid tumors. Current management strategies. Dis Colon Rectum 1997, 40: 1101-18.
  • Granberg D, Wilander E, Strisberg M, Granerus G, Skogseid B, Öberg K. Clinical symptons, hormone profiles,treatment and prognosis in patients with gastric carcinoid tumors. Gut 1998; 43: 223-8.
  • Jensen RT, Norton JA.Carcinoid tumors and carcinoid syndrome. En VT de Vita, S Hellman y SA Rosenmerg (eds), Cancer Principles and Practice of Oncology , Lippincott- Raven, Philadelphia 1997; 1704-1723.
  • Larrad Jiménez A. Síndrome carcinoide. Cir Esp 1997; 62: 224- 233.
  • Elizalde I, Borda F. Tratamiento actual del tumor carcinoide. Gastroenterol Hepatol 2002; 25 (8): 508-13.
  • Tomassetti P, Migliori M, Caletti GC, Fusaroli P, Corinaldesi R, Gullo L. Treatment of type II gastric carcinoids tumors with somatostatin analogues. N Engl J Med 2000; 343: 551-4.
  • Ahlman H, Kölby L, Lundell L, olbe L, Wängberg B, Granérus G, et al. Clinical management of gastric carcinoid tumors. Digestion 1994; 55(Suppl 3): 77-85.
  • Modlin Im, Gilligan CJ, Lawton GP, Tang LH, West AB, Darr U. Gastric carcinoids. The yale experience. Arch Surg 1995; 130. 250-5.
  • Rappel S, Altendorf-Hofmann A, Stolte M. Prognosis of gastric carcinoid tumours. Digestion 1995; 56: 455-62.
  • Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. Rapid regression of enterocromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992; 102: 1409- 18.
  • Rothmund M, Kisker O. Surgical treatment of carcinoid tumors of the small bowell, appendix, colon and rectum. Digestion 1994; 55(Suppl 3): 86-91.
  • Roggo A, Wood WC, Ottinger LW. Carcinoid tumors of the appendix. Ann Surg 1993; 217: 385-90.
  • Connor SJ, Hanna GB, Frizelle FA. Retrospective clinicophatologic analysis of appendiceal tumors from 7970 appendicectomies. Dis Colon Rectum 1998; 41: 67-71.
  • Sauven P, Ridge JA, Quan SH, Sigurdson ER. Anorectal carcinoid tumours. Ann Surg 1990; 211: 67-71.
  • Matsui K, Iwase T, Kitagawa M. Small polypoid-appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment. Am J Gastroenterol, 1993; 85: 1949-53.
  • Imada-Shirakata Y, Sakai M, Kajiyama T, Kin G, Inoue K, Torii A, et al. Endoscopic resection of rectal carcinoid tumors using aspiration lumpectomy. Endoscopy 1996; 28: 34-8.
  • Higaki S, Nishiaki M, Mitani N, Yanai H, Tada M, Okita K. Effectiveness of local endoscopic resection of rectal carcinoid tumors. Endoscopy 1997; 29: 171-5.
  • Jetmore AB, Ray JE, Gathright JB, McMullen KM, Hicks TC, Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum 1992; 35: 717-25.
  • Koura AN, Glacco GG, Curley SA, Skibber JM, Feig BW, Ellis LM. Carcinoid tumors of the rectum. Effect of size, histophatology, and surgical treatment on metastasis free survival. Cancer 1997; 79:1294-8.
  • Shirouzu K, Isomoto H, Kakegawa T. Treatment of rectal carcinoid tumors. Am J Surg 1990; 160: 262-5.
  • Larrad Jiménez A. Bases quirúrgicas del tratamiento de los tumores endocrinos del aparato digestivo. Cir Esp 1997; 61:440- 449.
  • Gregor M. Therapeutic principles in the management of metastasising carcinoid tumors: drugs for symptomatic treatment. Digestion 1994;55(Suppl 3):60-3.
  • Öberg K, Erikson B. The role of interferons in the management of carcinoid tumours. Br J Haematol 1991;79(Suppl 1):74-9.
  • Saslow SB, Scolapio JS, Camilleri M, Forstrom S, Thomforde GM, Burton DD, et al. Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. Gut 1998;42:628-34.
  • Halford S, Waxman J. The management of carcinoid tumours. Q J Med 1998;91:795-8.
  • Pazos A. Mediadores celulares I. Histamina y 5-hidroxitriptamina. Farmacología de la migraña. En: Flórez J, Armijo JA, Mediavilla A, editores. Farmacología humana. 3.a ed. Barcelona: Masson, 1997; p. 305-25.
  • Schwörer H, Münke, Stöckmann F, Ramador G. Treatment of diarrhea in carcinoid syndrome with ondansetron, tropisetron and clonidine. Am J Gastroenterol 1995;90:645-8.
  • Arnol R, Trautmann ME, Creutzfeldt W, Benning R, Bennig M, Neuhaus C, et al. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 1996;38:430-8.
  • Di Bartolomeo M, Bajetta E, Buzzoni R, Mariani L, Carnaghi C, Somma L, et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. Cancer 1996;77: 402-8.
  • Arnold R, Frank M, Kajdan U. Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues. Digestion 1994;55(Suppl 3):107-13.
  • Öberg K, Erikson B, Janson ET. Interferons alone or in combination with chemotherapy or other biologicals in the treatment of neuroendocrine gut and pancreatic tumors. Digestion 1994; 55(Suppl 3):64-9.
  • Frank M, Klose KJ, Wied M, Ishaque N, Schade-Brittinger C, Arnol R. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 1999; 94:1381-7.
  • Ruszniewskj P, Ducreux M, Chayvialle JA, Blumberg J, Cloarec D, Michel H, et al. Treatment of the carcinoid syndrome with the long acting somatostatin analogue lanreotide: a prospective study in 39 patients. Gut 1996;39:279-83.
  • Tomassetti P, Migliori M, Gullo L. Slow-release lanreotide treatment in endocrine gastrointestinal tumors. Am J Gastroenterol 1998;93:1468-71.
  • McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990;108:1091-6.
  • Ahlman H. The role of surgery in patients with advanced midgut carcinoid tumours. Digestion 1996;(Suppl 1):86-7.
  • Clouse ME, Perry L, Stuart K, Stokes KR. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestión 1994;55(Suppl 3):92-7.
  • Casanovas T. Trasplante hepático en los tumores primitivos y metastásicos del hígado exceptuando el hepatocarcinoma. Gastroenterol Hepatol 2001;24 (Supl 1):75-8.
  • Frilling A, Rogiers X, Knöfel WT, Broelsch CE. Liver transplantation for metastatic carcinoid tumors. Digestion 1994; 55(Suppl 3):104-6.
  • Chakravarthy A, Abrams RA. Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer 1995; 75:1386-90.
  • Jacobsen MB, Hanssen LE, Kolmannskog R, Schrumpf E, Vain MH, Bergan A. Interferon-alpha-2b, with or without prior hepatic artery embolization: clinical response and survival in midgut carcinoid patients. The Norwegian carcinoid study. Scand J Gastroenterol 1995; 30: 789-96.
  • Läuffer JM, Zhang T, Modlin IM. Review article: current status if gastrointestinal carcinoids. Aliment PharmacolTher. 1999; 13 (3): 271-287.
  • Boudreaux JP, Putty B, Frey DJ, et al. Surgical treatment of advanced-stagecarcinoid. Ann Surg. 2005; 241 (6): 839-845.
  • Van der Lely AJ, de Herder WW. Carcinoid syndrome: diagnosis and medical management. Arq Bras Endocrinol Metab. 2005; 49 (5): 850-60.
Fuente de los datos: Dialnet